Senior Media Relations Specialist

Amanda Gibbs

Senior Media Relations Specialist

503-494-8231

How much does it cost to bring a cancer drug to market?
By Amanda Gibbs September 11, 2017
A new study focused on the research and development spending of some pharmaceutical companies found the cost of bringing a cancer drug to market was significantly less than previously reported.
Research Week 2017: Why should anyone care about aflatoxins? Communicating the need for basic science around the world
By Amanda Gibbs May 01, 2017
Stephen Lloyd's recent research, published in the Proceedings of the National Academy of Sciences, drew upon his expertise as a cancer biologist and focused on a global health problem affecting hundreds of thousands of individuals in Southeast Asia and Sub-Saharan Africa, where a specific class of toxic compounds, called aflatoxins, are commonly found in food sources.
In search of treatment for a perilous form of leukemia
By Amanda Gibbs March 28, 2017
There’s an urgency in Anupriya Agarwal’s voice when she talks about her acute myeloid leukemia research: “We need to do something beyond what we’ve already done,” she said. “The treatment hasn’t changed in decades, and that can’t be our only answer.”
OHSU physician awarded $2 million to investigate health care practices that 'don’t work'
By Amanda Gibbs March 27, 2017
Vinay Prasad, M.D., M.P.H., has been awarded a $2 million grant to support an effort to uncover treatments and tests that are contradicted by reliable evidence. The three-year project calls for sharing the findings via a public website and developing teaching modules that can be incorporated into medical school or residency curricula.
The OHSU Knight – Legacy Health Cancer Collaborative program expands to Clark County
By Amanda Gibbs March 02, 2017
The OHSU Knight Cancer Institute and Legacy Health have signed business agreements with The Vancouver Clinic, or TVC, to expand their network of integrated adult cancer care clinics to southwest Washington. The agreement is the latest addition to the OHSU Knight-Legacy Health Cancer Collaborative, established in 2013.
Gene mutations cause leukemia, but which ones?
By Amanda Gibbs February 21, 2017
Research published today in the journal Oncotarget, sought to better understand one “typo” in a standard leukemia assay, or test. While studying cancer biology and completing his doctorate at the OHSU Knight Cancer Institute, Kevin Watanabe-Smith, Ph.D., encountered a new problem: an issue with the model system itself.
Mole Mapper app ‘crowd-sources’ photos for skin cancer research, prevention
By Amanda Gibbs February 14, 2017
Commenting on recent research findings from a team at Stanford University, Sancy Leachman, M.D., Ph.D., director of the OHSU Knight Cancer Institute’s Melanoma Research Program and chair of the Department of Dermatology in the OHSU School of Medicine, co-authored a Nature News and Views perspective that heralded artificial intelligence, or AI, an important step in the “final frontier” in cancer diagnosis.
Cancer survivor thanks her caregivers with a song
By Amanda Gibbs January 23, 2017
Suse Skinner, 70, is fighting her second battle with cancer. In 2005 she was diagnosed with breast cancer, then in August 2016 she was admitted to OHSU for her first induction chemotherapy session for acute myeloid leukemia, where she underwent 24/7 chemotherapy for six days followed by six weeks of recovery.
OHSU Knight Cancer Institute strongly endorses new HPV vaccine recommendations
By Amanda Gibbs January 11, 2017
Recognizing a critical need to improve national vaccination rates for human papillomavirus, or HPV, the OHSU Knight Cancer Institute has united with all 69 National Cancer Institute-designated cancer centers in issuing a joint statement in support of recently revised recommendations from the Centers for Disease Control and Prevention.
Treating cancer, mental health neglect in rural America
By Amanda Gibbs December 08, 2016
OHSU Knight Cancer Institute oncologist publishes New England Journal of Medicine “Perspective” on her experience treating a patient in rural Oregon with breast cancer and mental illness.
Study: Enhancing cancer response to radiation
By Amanda Gibbs November 28, 2016
OHSU researcher Sudarshan Anand, Ph.D., has a contemporary analogy to describe microRNA: “I sometimes compare MicroRNA to tweets — they’re short, transient and constantly changing.”